Contrary to the above data suggesting the pathogenic role of GSK3β hyperactivity in DKD, Mariappan et al. found that activation of GSK3β has a beneficial effect on diabetes-induced kidney damage [163]. This evidence concerns the gene GSK3B and diabetic kidney disease.